This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with adva…

Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more

~Estimated

~$10 – $8,750

VM Oncology, LLCNCT03556228

Phase 1

A Phase I Trial of Re-Irradiation With Concurrent Chemotherapy in Combination With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Squamous Cell Carcinoma

The purpose of this study is to evaluate the safety, tolerability and maximum tolerated dose of tislelizumab in combination with pamiparib plus chemoradiothera…

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+2 more

~Estimated

~$10 – $6,250

University of ChicagoNCT05526924